Pre-treatment plasma retinol binding protein 4 level and its change after treatments predict systemic treatment response in psoriasis patients.

BMC Immunol · 2024 · PMC11337756 · PMID 39169306

Europe PMC DOI

hedged sentences

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

a decreasing trendP = 0.078so close (0.05 < p ≤ 0.1)

did not reach statistical significanceno p-value reported

Subgroup analysis of the prognostic value of RBP4 based on treatment regimens in psoriasis patients Subgroup analysis revealed that RBP4 at baseline showed a decreasing trend in patients receiving MTX ( P = 0.078) and TNF inhibitor ( P = 0.084) who achieved PASI 75 at W12 compared to those who did not achieve it, but it did not reach statistical significance.

also in 47,180 other papers

showed a trendno p-value reported

Meanwhile, RBP4 at baseline showed a trend to be positively correlated with BMI in psoriasis patients but did not achieve statistical significance ( r = 0.194, P = 0.075).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.